Designing supramolecular therapies to cross the blood-brain barrier
A new Northwestern Medicine study has uncovered key molecular design principles that could help supramolecular therapeutics cross the blood-brain barrier, a major challenge for this novel approach to treating neurological disorders.
We haven't written up this one. Phys.org has the full story — the link below goes straight to it.